CHELIDONINE (3146)

Name	CHELIDONINE
Compound class	58059E72045
Compound code	ISOQUINOLINE ALKALOID

157 experiments

Experiment	Worktypes	Pharmacology	Organism (specimen)
689151	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Chelidonium majus (PAPAVERACEAE)
651323	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	Empty organism
959633	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYHPLC SEPARATION DATA FOR		Empty organism
987923	IDENTIFICATION OFQUANTITATIVE DATA REPORTED		Chelidonium majus (PAPAVERACEAE)
1264939	PHARMACOLOGY OF COMPOUND - IN VIVO	TOXICITY ASSESSMENT(QUANTITATIVE)	Empty organism
901326	PHARMACOLOGY OF COMPOUND - IN VIVO	HYPOTHERMIC ACTIVITY	Empty organism
965912	ISOLATION AND IDENTIFICATION OF		Chelidonium majus (PAPAVERACEAE)
1264946	PHARMACOLOGY OF COMPOUND - IN VIVO	ADRENOLYTIC(UNSPEC)	Empty organism
1264941	PHARMACOLOGY OF COMPOUND - IN VIVO	TOXICITY ASSESSMENT(QUANTITATIVE)	Empty organism
1254314	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)STRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	ANTIMYCOBACTERIAL ACTIVITY	Empty organism
11573	PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF	ANTITUMOR ACTIVITY	Chelidonium majus (PAPAVERACEAE)
943762	PHARMACOLOGY OF COMPOUND - IN VIVO	CATALEPTIC EFFECT	Empty organism
989735	IDENTIFICATION IN BY TLCWORK DESCRIBED MAINLY CONCERNS METHODOLOGYTLC DATA REPORTED		Chelidonium majus (PAPAVERACEAE)
780133	ISOLATION AND IDENTIFICATION OF		Bocconia frutescens (PAPAVERACEAE)
1212392	PHARMACOLOGY OF COMPOUND - IN VITRO	MONOOXYGENASE INHIBITION	Empty organism
995265	ISOLATION AND IDENTIFICATION OF		Glaucium vitellinum (PAPAVERACEAE)
901330	PHARMACOLOGY OF COMPOUND - IN VIVO	SPONTANEOUS ACTIVITY REDUCTION	Empty organism
418616	PHARMACOLOGY OF COMPOUND - IN VITRO	REVERSE TRANSCRIPTASE INHIBITION	Empty organism
1264912	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Empty organism
610592	PHARMACOLOGY OF COMPOUND - IN VITRO	GABA RECEPTOR BLOCKING EFFECT	Chelidonium majus (PAPAVERACEAE)
1015292	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Empty organism
1324743	ISOLATION AND IDENTIFICATION OF		Chelidonium majus (PAPAVERACEAE)
489438	PHARMACOLOGY OF COMPOUND - IN VITRO	MICROTUBULE EFFECTS	Empty organism
448535	PHARMACOLOGY OF COMPOUND - IN VITROREVIEW OF	ANTIVIRAL ACTIVITY	Chelidonium majus (PAPAVERACEAE)
19349	PHARMACOLOGY OF COMPOUND - IN VIVO	TOXICITY ASSESSMENT(QUANTITATIVE)	Empty organism
403837	ISOLATION AND IDENTIFICATION OF		Papaver nudicaule (PAPAVERACEAE)
61428	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMYCOBACTERIAL ACTIVITY	Empty organism
1264751	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIVIRAL ACTIVITY	Empty organism
821031	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION OFQUANTITATIVE DATA REPORTED		Chelidonium majus (PAPAVERACEAE)
610589	ISOLATION AND IDENTIFICATION OF		Chelidonium majus (PAPAVERACEAE)
943763	PHARMACOLOGY OF COMPOUND - IN VIVO	DOPAMINE DEPLETION	Empty organism
1043202	PLANT TISSUE CULTURE MARKER CODEISOLATION AND IDENTIFICATION OF		Chelidonium majus (PAPAVERACEAE)
1038693	IDENTIFICATION IN BY TLC		Chelidonium majus (PAPAVERACEAE)
677387	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTICONVULSANT ACTIVITY	Empty organism
396926	PHARMACOLOGY OF COMPOUND - IN HUMANSANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Chelidonium majus (PAPAVERACEAE)
761463	PHARMACOLOGY OF COMPOUND - IN VIVO	AMINOTRANSFERASE (ALT) INHIBITION	Empty organism
577717	IDENTIFICATION IN BY TLC		Chelidonium majus (PAPAVERACEAE)
500984	IDENTIFICATION IN BY HPLC		Chelidonium majus (PAPAVERACEAE)
603923	PHARMACOLOGY OF COMPOUND - IN VITRO	LIPOXYGENASE,5: INHIBITION	Chelidonium majus (PAPAVERACEAE)
489435	PHARMACOLOGY OF COMPOUND - IN VITRO	MICROTUBULE EFFECTS	Empty organism
956169	ISOLATION AND IDENTIFICATION OF		Stylophorum lasiocarpum (PAPAVERACEAE)
1324738	PHARMACOLOGY OF COMPOUND - IN HUMANS	ANALGESIC ACTIVITY	Chelidonium majus (PAPAVERACEAE)
913209	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	MOLLUSCICIDAL ACTIVITY	Empty organism
399334	ISOLATION AND IDENTIFICATION OF		Chelidonium majus (PAPAVERACEAE)
11569	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Chelidonium majus (PAPAVERACEAE)
1264945	PHARMACOLOGY OF COMPOUND - IN VIVO	HYPERTENSIVE ACTIVITY	Empty organism
603926	PHARMACOLOGY OF COMPOUND - IN VITRO	RADICAL SCAVENGING EFFECT	Chelidonium majus (PAPAVERACEAE)
489437	PHARMACOLOGY OF COMPOUND - IN VITRO	MICROTUBULE ASSEMBLY INHIBITION	Empty organism
1297007	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOPROTECTIVE ACTIVITY	Empty organism
515314	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYHPLC SEPARATION DATA FOR		Empty organism
351001	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF		Chelidonium majus (PAPAVERACEAE)
1259356	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIMITOTIC ACTIVITY	Empty organism
1254315	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)STRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	ANTIYEAST ACTIVITY	Empty organism
448534	ISOLATION AND IDENTIFICATION OF		Chelidonium majus (PAPAVERACEAE)
1269192	ISOLATION AND IDENTIFICATION OF		Chelidonium majus (PAPAVERACEAE)
901323	PHARMACOLOGY OF COMPOUND - IN VIVO	SPONTANEOUS ACTIVITY REDUCTION	Empty organism
396927	PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS	ANALGESIC ACTIVITY	Chelidonium majus (PAPAVERACEAE)
1264766	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	INTRAOCULAR PRESSURE INCREASED	Empty organism
998105	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Empty organism
452377	IDENTIFICATION IN BY TLCQUANTITATIVE DATA REPORTED		Chelidonium majus (PAPAVERACEAE)
11574	PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF	ANTITUMOR ACTIVITY	Chelidonium majus (PAPAVERACEAE)
689152	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIFUNGAL ACTIVITY	Chelidonium majus (PAPAVERACEAE)
610591	PHARMACOLOGY OF COMPOUND - IN VITRO	GABA RECEPTOR BLOCKING EFFECT	Chelidonium majus (PAPAVERACEAE)
418617	PHARMACOLOGY OF COMPOUND - IN VITRO	REVERSE TRANSCRIPTASE INHIBITION	Empty organism
603925	PHARMACOLOGY OF COMPOUND - IN VITRO	LIPOXYGENASE INHIBITION	Chelidonium majus (PAPAVERACEAE)
610593	PHARMACOLOGY OF COMPOUND - IN VITRO	GABA RECEPTOR BLOCKING EFFECT	Chelidonium majus (PAPAVERACEAE)
1015293	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIYEAST ACTIVITY	Empty organism
491841	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	INSECTICIDE ACTIVITY	Empty organism
54855	BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY		Chelidonium majus (PAPAVERACEAE)
761465	PHARMACOLOGY OF COMPOUND - IN VIVO	ASPARTATE AMINOTRANSFERASE INDUCTION	Empty organism
1264949	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	Empty organism
780134	PHARMACOLOGY OF COMPOUND - IN VITRO	ANGIOTENSIN II RECEPTOR BINDING INHIBITION	Bocconia frutescens (PAPAVERACEAE)
382457	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Chelidonium majus (PAPAVERACEAE)
991754	PRESENT IN (REVIEW)TOXICITY MARKER CODEPHARMACOLOGY OF EXTRACT - IN HUMANS	TOXIC EFFECT(GENERAL)	Symphoricarpos albus (CAPRIFOLIACEAE)
901322	PHARMACOLOGY OF COMPOUND - IN VIVO	TOXICITY ASSESSMENT(QUANTITATIVE)	Empty organism
845831	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Stylophorum diphyllum (PAPAVERACEAE)
1264942	PHARMACOLOGY OF COMPOUND - IN VIVO	TOXICITY ASSESSMENT(QUANTITATIVE)	Empty organism
901327	PHARMACOLOGY OF COMPOUND - IN VIVO	ANALGESIC ACTIVITY	Empty organism
535806	ISOLATION AND IDENTIFICATION OF		Chelidonium majus (PAPAVERACEAE)
610590	PHARMACOLOGY OF COMPOUND - IN VITRO	GABA RECEPTOR BLOCKING EFFECT	Chelidonium majus (PAPAVERACEAE)
1264947	PHARMACOLOGY OF COMPOUND - IN VIVO	ANESTHETIC ACTIVITY(LOCAL)	Empty organism
585705	PHARMACOLOGY OF COMPOUND - IN VITRO	DNA LIGASE INHIBITION	Empty organism
978752	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Symphoricarpos albus (CAPRIFOLIACEAE)
489436	PHARMACOLOGY OF COMPOUND - IN VITRO	MICROTUBULE EFFECTS	Empty organism
603928	PHARMACOLOGY OF COMPOUND - IN VITRO	LIPID PEROXIDE FORMATION INHIBITION	Chelidonium majus (PAPAVERACEAE)
1038690	IDENTIFICATION IN BY TLC		Chelidonium majus (PAPAVERACEAE)
1254312	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)STRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	ANTIBACTERIAL ACTIVITY	Empty organism
349559	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF		Chelidonium majus (PAPAVERACEAE)
901324	PHARMACOLOGY OF COMPOUND - IN VIVO	SPONTANEOUS ACTIVITY REDUCTION	Empty organism
1264738	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	ANTIMITOTIC ACTIVITY	Empty organism
1259355	PHARMACOLOGY OF COMPOUND - IN VIVOTOXICITY MARKER CODE	TOXICITY ASSESSMENT(QUANTITATIVE)	Empty organism
603924	PHARMACOLOGY OF COMPOUND - IN VITRO	LIPOXYGENASE,12: INHIBITION	Chelidonium majus (PAPAVERACEAE)
1269352	ISOLATION AND IDENTIFICATION OF		Hylomecon vernalis (PAPAVERACEAE)
973514	IDENTIFICATION IN BY TLCWORK DESCRIBED MAINLY CONCERNS METHODOLOGYTLC DATA REPORTED		Chelidonium majus (PAPAVERACEAE)
24827	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Chelidonium majus (PAPAVERACEAE)
980424	PARTIAL SYNTHESIS OF		Empty organism
11570	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Chelidonium majus (PAPAVERACEAE)
1264948	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	Empty organism
539599	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF		Chelidonium majus (PAPAVERACEAE)
551204	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDIDENTIFICATION IN BY HPLCQUANTITATIVE DATA		Chelidonium majus (PAPAVERACEAE)
619797	YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Chelidonium majus (PAPAVERACEAE)
957780	PHARMACOLOGY OF COMPOUND - IN VITRO	REVERSE TRANSCRIPTASE INHIBITION	Empty organism
708231	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Chelidonium majus (PAPAVERACEAE)
1270607	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODEREVIEW OF	ANTITUMOR ACTIVITY	Empty organism
585704	PHARMACOLOGY OF COMPOUND - IN VITRO	DNA LIGASE INHIBITION	Empty organism
396924	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF		Chelidonium majus (PAPAVERACEAE)
55062	PHARMACOLOGY OF COMPOUND - IN VITRO	CHOLINESTERASE INHIBITION	Empty organism
570002	QUANTITATIVE DATAAGRONOMIC STUDIES REPORTEDISOLATION AND IDENTIFICATION OF		Chelidonium majus (PAPAVERACEAE)
1184536	IDENTIFICATION IN BY HPLC		Chelidonium majus (PAPAVERACEAE)
946094	ISOLATION AND IDENTIFICATION OF		Chelidonium majus (PAPAVERACEAE)
1015290	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Empty organism
11571	PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF	ANTITUMOR ACTIVITY	Chelidonium majus (PAPAVERACEAE)
1264943	PHARMACOLOGY OF COMPOUND - IN VIVO	TOXICITY ASSESSMENT(QUANTITATIVE)	Empty organism
489641	PHARMACOLOGY OF COMPOUND - IN VITRO	LIPID PEROXIDE FORMATION INHIBITION	Empty organism
945346	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	REVERSE TRANSCRIPTASE INHIBITION	Empty organism
741715	PHARMACOLOGY OF COMPOUND - IN VITRO	LIPASE INHIBITION	Empty organism
780135	PHARMACOLOGY OF COMPOUND - IN VITRO	ENDOTHELIN A RECEPTOR BINDING INHIBITION	Bocconia frutescens (PAPAVERACEAE)
1264742	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)STRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	CYTOTOXIC ACTIVITY	Empty organism
651324	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	Empty organism
1254311	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)STRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	ANTIBACTERIAL ACTIVITY	Empty organism
901328	PHARMACOLOGY OF COMPOUND - IN VIVO	SPASMOLYTIC ACTIVITY	Empty organism
1264940	PHARMACOLOGY OF COMPOUND - IN VIVO	TOXICITY ASSESSMENT(QUANTITATIVE)	Empty organism
448536	PHARMACOLOGY OF COMPOUND - IN VITROREVIEW OF	ANTIVIRAL ACTIVITY	Chelidonium majus (PAPAVERACEAE)
943761	PHARMACOLOGY OF COMPOUND - IN VIVO	CNS DEPRESSANT ACTIVITY	Empty organism
948384	IDENTIFICATION IN BY HPLC		Chelidonium majus (PAPAVERACEAE)
1254313	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)STRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	ANTIBACTERIAL ACTIVITY	Empty organism
551207	IDENTIFICATION IN BY HPLCQUANTITATIVE DATAHPLC SEPARATION DATA FOR		Chelidonium majus (PAPAVERACEAE)
11572	PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF	ANTITUMOR ACTIVITY	Chelidonium majus (PAPAVERACEAE)
636835	IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED		Chelidonium majus (PAPAVERACEAE)
347020	PHARMACOLOGY OF COMPOUND - IN VITRO	LACTATE DEHYDROGENASE STIMULATION	Empty organism
1179267	PHARMACOLOGY OF COMPOUND - IN VITRO	REVERSE TRANSCRIPTASE INHIBITION	Empty organism
1270606	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODEREVIEW OF	ANTITUMOR ACTIVITY	Empty organism
901325	PHARMACOLOGY OF COMPOUND - IN VIVO	BARBITURATE POTENTIATION	Empty organism
347014	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF		Chelidonium majus (PAPAVERACEAE)
347019	PHARMACOLOGY OF COMPOUND - IN VITRO	CELL PROLIFERATION INHIBITION	Empty organism
418615	PHARMACOLOGY OF COMPOUND - IN VITRO	REVERSE TRANSCRIPTASE INHIBITION	Empty organism
946048	IDENTIFICATION IN BY HPLC		Chelidonium majus (PAPAVERACEAE)
901329	PHARMACOLOGY OF COMPOUND - IN VIVO	SPONTANEOUS ACTIVITY REDUCTION	Empty organism
677388	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTICONVULSANT ACTIVITY	Empty organism
606438	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDWORK DESCRIBED MAINLY CONCERNS METHODOLOGYINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Chelidonium majus (PAPAVERACEAE)
577716	IDENTIFICATION IN BY TLC		Chelidonium majus (PAPAVERACEAE)
515221	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTEDHPLC SEPARATION DATA FOR		Chelidonium majus (PAPAVERACEAE)
1015291	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Empty organism
998104	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Empty organism
489439	PHARMACOLOGY OF COMPOUND - IN VITRO	MICROTUBULE EFFECTS	Empty organism
29660	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYQUANTITATIVE DATA REPORTEDISOLATION AND IDENTIFICATION OF		Chelidonium majus (PAPAVERACEAE)
1264944	PHARMACOLOGY OF COMPOUND - IN VIVO	HYPERTENSIVE ACTIVITY	Empty organism
603927	PHARMACOLOGY OF COMPOUND - IN VITRO	PROOXIDANT ACTIVITY	Chelidonium majus (PAPAVERACEAE)
1254310	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)STRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	ANTIBACTERIAL ACTIVITY	Empty organism
396925	PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS	ANTITUSSIVE ACTIVITY	Chelidonium majus (PAPAVERACEAE)
761464	PHARMACOLOGY OF COMPOUND - IN VIVO	ALANINE AMINOTRANSFERASE STIMULATION	Empty organism
51609	ISOLATION AND IDENTIFICATION OF		Chelidonium majus (PAPAVERACEAE)
1015289	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Empty organism
347148	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF		Chelidonium majus (PAPAVERACEAE)
991801	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF		Chelidonium majus (PAPAVERACEAE)
754976	PHARMACOLOGY OF COMPOUND - IN VITRO	TUBULIN POLYMERIZATION INHIBITION	Empty organism
603922	ISOLATION AND IDENTIFICATION OF		Chelidonium majus (PAPAVERACEAE)

CHELIDONINE (3146)

Compound Details

Summary

Experiments (157)

Filters

Worktypes (33)

Pharmacology (51)

Compounds (197)

Organisms (91)

Show SPARQL Queries (1)

Query 1